Antiangiogenesis Therapy with Bevacizumab Improves Survival in Metastatic or Relapsed Cervical Cancer

Article Information

DOI 
http://dx.doi.org/10.1177/155989771306005
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Wayne Kuznar
  1. Krishnansu S. Tewari, MD
    1. University of California Irvine, Irvine, California, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015100
Jun 2015300
Jul 2015100
Aug 2015200
Sep 2015100
Oct 2015143
Nov 2015300
Total1843

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Antiangiogenesis Therapy with Bevacizumab Improves Survival in Metastatic or Relapsed Cervical Cancer
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Oncology Clinical Trials
Reproductive Cancers
Oncology Clinical Trials
Reproductive Cancers
Oncology